Turning Point Brands completed the $15m investment in dosist.

Turning Point Brands, a manufacturer, marketer and distributor of branded consumer products with active ingredients, completed the $15m investment in dosist, a global cannabinoid company. "Turning Point’s leadership team has demonstrated remarkable foresight and vision about the future and opportunity for federally legal cannabinoid products. The synergy between our brands around this scope and mission is incredible and we are excited by what we will achieve together with this partnership," Gunner Winston, dosist CEO.